查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1937595

全球靜脈血栓栓塞症治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Venous Thromboembolism Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 211 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計靜脈血栓栓塞症治療市場規模將從 2025 年的 18.9 億美元成長到 2034 年的 28.2 億美元，2026 年至 2034 年的複合年成長率為 4.53%。

受靜脈血栓栓塞症（VTE）疾病（包括深層靜脈栓塞症（DVT）和肺動脈栓塞（PE））盛行率不斷上升的推動，VTE治療市場正經歷顯著成長。隨著人們對VTE相關風險的認知不斷提高，醫療機構正將有效的預防和治療策略置於優先地位。由於臨床醫師致力於改善患者預後並降低VTE相關併發症的發生率，包括直介面服抗凝血劑（DOAC）和傳統抗凝血劑在內的抗凝血治療需求激增。

治療方案和給藥方法的創新正在塑造VTE治療市場的未來前景。新型抗凝血劑的研發，憑藉其更高的安全性和更最佳化的給藥方案，正在改善VTE的治療環境。此外，病患監測技術的進步，例如穿戴式裝置和遠端醫療解決方案，使醫療服務提供者能夠更有效地追蹤患者的用藥依從性和治療效果。隨著對VTE潛在機制研究的深入，市場有望推出針對特定風險因素和患者群體的標靶治療。

此外，隨著製藥公司和學術機構認知到該領域尚未滿足的需求，加大對臨床研究和開發的投入將對靜脈血栓栓塞症（VTE）治療市場產生積極影響。醫療服務提供者、研究人員和相關人員之間的合作對於推進臨床試驗和確保創新治療方法的成功應用至關重要。在這種不斷變化的環境下，監管機構有望簡化新治療方法的核准流程，並促進VTE患者快速獲得有效治療方法。隨著預防、早期發現和個人化治療方案的重要性日益凸顯，將VTE管理納入綜合醫療保健策略以改善患者預後的重要性也將日益凸顯。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球靜脈血栓栓塞症治療市場：依產品分類

  • 市場分析、洞察與預測
  • 非分段式氣動壓縮泵
  • 分段式無梯度氣動壓縮泵
  • 分段式氣動壓縮幫浦（含校準梯度）
  • 上肢氣動加壓袖套
  • 下肢氣動加壓袖套
  • 永久性下腔靜脈濾器
  • 可回收下腔靜脈濾器
  • 用於栓塞的球囊導管
  • 經皮血栓切除裝置
  • 導管導引溶栓（CDT）裝置

第5章 全球靜脈血栓栓塞症治療市場：依適應症分類

  • 市場分析、洞察與預測
  • 深層靜脈栓塞症
  • 肺動脈栓塞

第6章 全球靜脈血栓栓塞症治療市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院
  • 導管檢查室
  • 門診手術中心

第7章 全球靜脈血栓栓塞症治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Stryker Corporation
    • Argon Medical Devices
    • Cardinal Health（Medtronic）
    • Cook Medical
    • Boston Scientific Corporation
    • Koninklijke Philips NV
    • Arjo
    • DJO Global
簡介目錄
Product Code: VMR11215191

The Venous Thromboembolism Treatment Market size is expected to reach USD 2.82 Billion in 2034 from USD 1.89 Billion (2025) growing at a CAGR of 4.53% during 2026-2034.

The venous thromboembolism (VTE) treatment market is experiencing significant growth, driven by the increasing prevalence of VTE conditions, including deep vein thrombosis (DVT) and pulmonary embolism (PE). As awareness of the risks associated with VTE rises, healthcare providers are prioritizing effective prevention and treatment strategies. The market is witnessing a surge in demand for anticoagulant therapies, including direct oral anticoagulants (DOACs) and traditional anticoagulants, as clinicians seek to improve patient outcomes and reduce the incidence of VTE-related complications.

Innovations in treatment options and delivery methods are shaping the future of the VTE treatment market. The development of novel anticoagulant agents with improved safety profiles and dosing regimens is enhancing the therapeutic landscape for VTE management. Additionally, advancements in patient monitoring technologies, such as wearable devices and telehealth solutions, are enabling healthcare providers to track patient adherence and outcomes more effectively. As research continues to explore the underlying mechanisms of VTE, the market is likely to witness the introduction of targeted therapies that address specific risk factors and patient populations.

Moreover, the VTE treatment market will benefit from increased investment in clinical research and development, as pharmaceutical companies and academic institutions recognize the unmet needs in this area. Collaborative efforts between healthcare providers, researchers, and industry stakeholders will be essential in advancing clinical trials and ensuring the successful implementation of innovative therapies. As the landscape evolves, regulatory bodies are expected to streamline approval processes for new treatments, facilitating faster access to effective solutions for patients with VTE. The focus will increasingly shift towards integrating VTE management into comprehensive healthcare strategies, emphasizing the importance of prevention, early detection, and personalized treatment plans in improving patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Non-Segmented Pneumatic Compression Pumps
  • Segmented Pneumatic Compression Pumps without Gradient
  • Segmented Pneumatic Compression Pumps with Calibrated Gradient
  • Upper Pneumatic Compression Sleeves
  • Lower Pneumatic Compression Sleeves
  • Permanent Inferior Vena Cava Filters
  • Retrievable Inferior Vena Cava Filters
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) Devices

By Disease Indication

  • Deep Venous Thrombosis
  • Pulmonary Embolism

By End User

  • Hospitals
  • Catheterisation Laboratories
  • Ambulatory Surgical Centres

COMPANIES PROFILED

  • Stryker Corporation, Argon Medical Devices, Cardinal Health Medtronic, Cook Medical, Boston Scientific Corporation, Koninklijke Philips NV, Arjo, DJO Global

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN and Units)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Non-Segmented Pneumatic Compression Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.3. Segmented Pneumatic Compression Pumps without Gradient Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.4. Segmented Pneumatic Compression Pumps with Calibrated Gradient Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.5. Upper Pneumatic Compression Sleeves Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.6. Lower Pneumatic Compression Sleeves Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.7. Permanent Inferior Vena Cava Filters Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.8. Retrievable Inferior Vena Cava Filters Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.9. Embolectomy Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.10. Percutaneous Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.11. Catheter-Directed Thrombolysis (CDT) Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET: BY DISEASE INDICATION 2022-2034 (USD MN and Units)

  • 5.1. Market Analysis, Insights and Forecast Disease Indication
  • 5.2. Deep Venous Thrombosis Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 5.3. Pulmonary Embolism Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET: BY END USER 2022-2034 (USD MN and Units)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 6.3. Catheterisation Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 6.4. Ambulatory Surgical Centres Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET: BY REGION 2022-2034(USD MN and Units)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.2.1 By Product
    • 7.2.2 By Disease Indication
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.3.1 By Product
    • 7.3.2 By Disease Indication
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.4.1 By Product
    • 7.4.2 By Disease Indication
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.5.1 By Product
    • 7.5.2 By Disease Indication
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.6.1 By Product
    • 7.6.2 By Disease Indication
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL VENOUS THROMBOEMBOLISM TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Stryker Corporation
    • 9.2.2 Argon Medical Devices
    • 9.2.3 Cardinal Health (Medtronic)
    • 9.2.4 Cook Medical
    • 9.2.5 Boston Scientific Corporation
    • 9.2.6 Koninklijke Philips N.V
    • 9.2.7 Arjo
    • 9.2.8 DJO Global